Cochrane is proud to be one of the world’s leading producers of trusted evidence. To maintain that standard, we need to innovate and make sure we are meeting the needs of the people using our evidence. We are making some major changes, one of which is the introduction of a new focused review format. We're simplifying and streamlining our review…
Roses Parker started with Cochrane in 2019 as a Network Support Fellow and is now a Commissioning Editor in the Evidence Production and Methods Directorate. Roses has previously held roles as a Staff Nurse, Data Analyst, and Research Assistant, all standing her in good stead for the role. Here, Roses explains how her new role will help…
We are delighted to announce the launch of the first complete version and print edition of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. After substantive work over the years, this version is now freely available online via the Cochrane Training website and in printed and e-book form, which can be purchased from the…
Cochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things the same way and the field has evolved during that time. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023 so that we can more…
The Governing Board met face-to-face in Paris in 20 May 2023. Members of the Board are Trustees of the Cochrane Charity and have overall responsibility for ensuring that Cochrane complies with our governing document, Charity Commission regulations and the law. The Co- Chairs of Council are members of the Governing Board but are not Trustees, they…
Cochrane is dedicated to improving the maintenance of our reviews and enhancing access to clear, useful health information.
As part of this, Cochrane will be changing the reporting guidance that our authors use. We will be using publishing standard guidelines, such as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA…
Cochrane has now fully upgraded to RevMan Web, meaning RevMan 5, the desktop version, is no longer available. Authors now have access to a new data management feature – study centric data - when creating new reviews. For ongoing protocols and reviews, switching this feature on is simple and can be done yourself.
Overview of study centric…
Nominate your Cochrane colleagues for prizes and awards by 12 June 2023.
Every year Cochrane awards members of its Community with a range of prizes that highlight high-quality methodological research, supporting health decision-making in developing countries, and contributors who have made a significant contribution to the organization.
The…
Today marks the closure of the UK-based Cochrane Review Groups whose funding from the National Institute for Health and Care Research (NIHR) has come to an end.
Over Cochrane’s 30-year history, thanks to the work of Cochrane Review Groups, over 16,000 new and updated Cochrane Reviews have been published covering a wide range of disciplines. These…
In February 2022, Cochrane's Governing Board approved the proposed change to Cochrane’s evidence synthesis production model. We know this is a profound shift, leading to all kinds of questions, and new ideas right across the Cochrane community.
Our key focus since March 2022 has been to deliver more detailed plans about the model, begin…
The Anne Anderson Award recognizes a female member of Cochrane who has made a significant contribution to the enhancement and visibility of women's participation within Cochrane. The winner then designates the cash award to assist a woman from a low-resource setting with her Cochrane activities. Here the winner of the 2022 cash award…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details.
Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance, integrity…
A number of stipends and bursaries are available to help consumers and other attendees based in developing countries to attend Cochrane Colloquium London 2023. This is our 30th annual flagship event and this year it will take place at Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details.
Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance,…
Dr. Vaibhav Sahni holds dual specialisations in the fields of Oral and Maxillofacial Surgery as well as Periodontics. He also holds the MFDS RCPS (Glasg), MFDS RCSEd and the AssocFCGDent. His areas of expertise include, in addition to the general purview of oral health, maxillofacial injuries, point of care diagnostics, oral-systemic interactions…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details.
Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance,…
Cochrane switched from using its first risk of bias tool to using the updated version, RoB 2, in 2019. Cochrane adopted a phased approach allowing authors to decide when to use it and offering them support from the editorial team. A paper outlining their experience and lessons learned has been published in BMJ Evidence-Based Medicine.
The…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details.
Why is Cochrane launching a new journal? And why now? Over the coming weeks we’ll discuss Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration…
Cochrane London 2023: Forward together for trusted evidence
4-6 September 2023
Central London, UK
Cochrane UK is delighted to be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London, UK from the 4 to 6 of September 2023, with satellite events and meetings on the 3rd September.…
Cochrane is closing out a year of significant change and challenges with positive news of a major milestone in our transition to a more streamlined and sustainable organization. Following an open and rigorous application process, we are pleased to announce the first set of pilot Cochrane Thematic Groups – each mapping to key areas of global health…
Cochrane is proud to be one of the world’s leading producers of trusted evidence. To maintain that standard, we need to innovate and make sure we are meeting the needs of the people using our evidence. We are making some major changes, one of which is the introduction of a new focused review format. We're simplifying and streamlining our review…
Roses Parker started with Cochrane in 2019 as a Network Support Fellow and is now a Commissioning Editor in the Evidence Production and Methods Directorate. Roses has previously held roles as a Staff Nurse, Data Analyst, and Research Assistant, all standing her in good stead for the role. Here, Roses explains how her new role will help…
We are delighted to announce the launch of the first complete version and print edition of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. After substantive work over the years, this version is now freely available online via the Cochrane Training website and in printed and e-book form, which can be purchased from the…
Cochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things the same way and the field has evolved during that time. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023 so that we can more…
The Governing Board met face-to-face in Paris in 20 May 2023. Members of the Board are Trustees of the Cochrane Charity and have overall responsibility for ensuring that Cochrane complies with our governing document, Charity Commission regulations and the law. The Co- Chairs of Council are members of the Governing Board but are not Trustees, they…
Cochrane is dedicated to improving the maintenance of our reviews and enhancing access to clear, useful health information. As part of this, Cochrane will be changing the reporting guidance that our authors use. We will be using publishing standard guidelines, such as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA…
Cochrane has now fully upgraded to RevMan Web, meaning RevMan 5, the desktop version, is no longer available. Authors now have access to a new data management feature – study centric data - when creating new reviews. For ongoing protocols and reviews, switching this feature on is simple and can be done yourself. Overview of study centric…
Nominate your Cochrane colleagues for prizes and awards by 12 June 2023. Every year Cochrane awards members of its Community with a range of prizes that highlight high-quality methodological research, supporting health decision-making in developing countries, and contributors who have made a significant contribution to the organization. The…
Today marks the closure of the UK-based Cochrane Review Groups whose funding from the National Institute for Health and Care Research (NIHR) has come to an end. Over Cochrane’s 30-year history, thanks to the work of Cochrane Review Groups, over 16,000 new and updated Cochrane Reviews have been published covering a wide range of disciplines. These…
In February 2022, Cochrane's Governing Board approved the proposed change to Cochrane’s evidence synthesis production model. We know this is a profound shift, leading to all kinds of questions, and new ideas right across the Cochrane community. Our key focus since March 2022 has been to deliver more detailed plans about the model, begin…
The Anne Anderson Award recognizes a female member of Cochrane who has made a significant contribution to the enhancement and visibility of women's participation within Cochrane. The winner then designates the cash award to assist a woman from a low-resource setting with her Cochrane activities. Here the winner of the 2022 cash award…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details. Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance, integrity…
A number of stipends and bursaries are available to help consumers and other attendees based in developing countries to attend Cochrane Colloquium London 2023. This is our 30th annual flagship event and this year it will take place at Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details. Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance,…
Dr. Vaibhav Sahni holds dual specialisations in the fields of Oral and Maxillofacial Surgery as well as Periodontics. He also holds the MFDS RCPS (Glasg), MFDS RCSEd and the AssocFCGDent. His areas of expertise include, in addition to the general purview of oral health, maxillofacial injuries, point of care diagnostics, oral-systemic interactions…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details. Why is Cochrane launching a new journal? And why now? We’re discussing Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration, relevance,…
Cochrane switched from using its first risk of bias tool to using the updated version, RoB 2, in 2019. Cochrane adopted a phased approach allowing authors to decide when to use it and offering them support from the editorial team. A paper outlining their experience and lessons learned has been published in BMJ Evidence-Based Medicine. The…
Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, recently opened for submissions! See our announcement for full details. Why is Cochrane launching a new journal? And why now? Over the coming weeks we’ll discuss Cochrane Evidence Synthesis and Methods in relation to Cochrane’s four key values: Collaboration…
Cochrane London 2023: Forward together for trusted evidence 4-6 September 2023 Central London, UK Cochrane UK is delighted to be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London, UK from the 4 to 6 of September 2023, with satellite events and meetings on the 3rd September.…
Cochrane is closing out a year of significant change and challenges with positive news of a major milestone in our transition to a more streamlined and sustainable organization. Following an open and rigorous application process, we are pleased to announce the first set of pilot Cochrane Thematic Groups – each mapping to key areas of global health…